多发性骨髓瘤中的MRD:临床前景
Tommaso Caravita di Toritto1, Angela Rago1
1UOSD Ematologia, ASL Roma 1, Rome, Italy.
Frontiers in oncology
|March 16, 2026
概括
在多发性骨髓瘤 (MM) 中,最小残留疾病 (MRD) 监测对于评估治疗有效性至关重要. 实现MRD阴性与明显更长的无进展和整体存活相关,指导未来的MM疗法.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 最小残留疾病 (MRD) 是多发性骨髓瘤 (MM) 的关键预后指标.
- 传统的完全缓解评估不足以准确评估治疗疗效.
- 高灵敏度测试对于检测低水平的残留疾病至关重要.
研究的目的:
- 审查目前用于检测多发性骨髓瘤 (MM) 中最小残留疾病 (MRD) 的方法.
- 在临床试验的背景下讨论MRD评估的解释.
- 探索MRD如何指导MM的未来治疗策略.
主要方法:
- 使用高灵敏度技术,如下一代流细胞计 (NGF) 和下一代测序 (NGS).
- 使用基因特异性寡核酸定量PCR用于MRD检测.
- 分析涉及MRD评估的关键临床试验数据.
主要成果:
- 实现MRD负面性始终与改善无进展存活率 (PFS) 和整体存活率 (OS) 相关.
- 监管机构承认MRD消极性是临床益处的验证代用物.
- MRD检测水平范围从10-5到10-6之间.
结论:
- 评估MRD可以更准确地评估MM的治疗疗效.
- MRD 消极性是多发性骨髓瘤中有利的长期结果的强有力的预测因素.
- 将MRD评估纳入临床实践为个性化MM治疗策略提供了一个框架.
更多相关视频
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
9.1K
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.6K
相关概念视频
Treatment Resistant Cancers
3.9K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers
1.5K
1.5K
Tumor Progression
7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Tumor Progression
3.5K
3.5K
